Table 3.
Table | Type of a Preparation, Doses Tested |
Pharmacological Mechanisms of Action | Values | Reference |
---|---|---|---|---|
Carrageenan-induced paw edema test | Essential oil, oral administration 30 min before introduction of carrageenan, 2, 20, and 200 μL/kg, vehicle (isosaline NaCl 0.9%), and sodium diclofenac (50 mg/kg, orally) as the reference drug |
Reducing the paw edema induced using carrageenan injection in mice | The levels of edema inhibition,12.27 ± 3.94% and 9.29 ± 3.94%, at 200 and 20 μL/kg, respectively, were comparable to the level observed using sodium diclofenac (11.43 ± 6.07%) | [60] |
Circular excision wound model in rats followed by histological examination | The cream prepared from the essential oil (0.5% w/w) | Decreasing in unhealed wound area | Significant decrease in unhealed wound area between the 6th (1.67 ± 0.14 mm2) and 9th (0.49 ± 0.22 mm2) day of treatment in comparison with the vehicle and madecassol on 6th day (2.32 ± 0.77 mm2 and 2.23 ± 0.35 mm2, respectively) | |
Murine macrophage cell line RAW 264.7 stimulated with LPS | The ethanolic extract of M. piperita, 25, 50, and 100 µg/mL | Reducing the LPS-induced production of NO, TNF-a, and IL-6 compared with untreated control | Reducing NO secretion in a concentration-dependent manner by 7.06, 18.85, and 41.88%, respectively. Suppression of TNF-a secretion by 20.71, 34.74, and 42.95%. Reducing IL-6 levels by 27.00, 43.71, and 51.85%. Inhibition of PGE2 production. |
[12] |
PBMCs | Essential oil, 0.01 µL/mL |
Reducing IL-4 production depends on cultivar and place of growing. | [102] | |
5-LOX inhibition assay | Essential oil | 5-LOX inhibition | IC50 were 0.08 and 0.03 μL/mL depending on the cultivar | [80] |
Activating antioxidant enzymes, the survival of peritoneal macrophage stimulated with lipopolysaccharide | The hydroalcoholic leaf extract of M. piperita grown in Brazil | Activating superoxide dismutase and glutathione peroxidase. Lowering the levels of H2O2. The survival was observed at the lower concentrations of the extract (1–30 µg/mL), while higher concentrations of the extract did decrease viability in the absence of lipopolysaccharides. | No data | [85] |